RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:DNA lesion-gated dumbbell nanodevices enable on-demand activation of the cGAS-STING pathway for enhancing cancer immunotherapy.
DNA lesion-gated dumbbell nanodevices enable on-demand activation of the cGAS-STING pathway for enhancing cancer immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
利用cGAS-STING通路对抗免疫逃逸是增强癌症免疫治疗最有前景的策略之一。然而,当前激活cGAS-STING通路的技术往往面临两难困境,主要源于疗效与安全性之间的平衡。
在此,我们开发了一种尿嘧啶碱基损伤门控哑铃DNA纳米器件(UBLE),能够在肿瘤细胞中按需激活和终止cGAS-STING通路,从而增强癌症免疫治疗。UBLE在茎部整合了两个脱氧尿苷(dU)用于DNA损伤识别,两个锁定的互补引物序列(引物A和B)用于DNA自组装,以及在环部连接了一个Förster共振能量转移对(Cy3和Cy5)用于激活评估。在肿瘤特异性修复指标(UDG和APE1)的正交识别下,UBLE发生构象变化,产生大量带切口的双链DNA(dsDNA)单元。这些单元自组装生成长的荧光dsDNA结构,允许选择性评估和按需激活cGAS-STING通路。
此外,我们证明UBLE能够有效激活肿瘤细胞中的cGAS-STING通路,增强NK细胞靶向的癌症免疫治疗。这项工作开发了一种DNA损伤门控策略,用于按需激活和终止cGAS-STING通路,为增强癌症免疫治疗提供了一条创新途径。
Utilizing the cGAS-STING pathway to combat immune evasion is one of the most promising strategies for enhancing cancer immunotherapy.
However, current techniques for activating the cGAS-STING pathway often face a dilemma, mainly due to the balance between efficacy and safety.
Here, we develop a uracil base lesion-gated dumbbell DNA nanodevice (UBLE) that allows on-demand activation and termination of the cGAS-STING pathway in tumor cells, thereby enhancing cancer immunotherapy. The UBLE integrates two deoxyuridines (dU) in the stem for DNA lesion recognition, two locked complementary primer sequences (primers A and B) for DNA self-assembly, and a Förster resonance energy transfer pair (Cy3 and Cy5) attached to the loop for activation assessment.
Upon the orthogonal recognition of tumor-specific repair indicators (UDG and APE1), the UBLE undergoes a conformational change to create massive nicked double-stranded DNA (dsDNA) units. These units self-assemble to generate long fluorescent dsDNA structures, permitting selective evaluation and on-demand activation of the cGAS-STING pathway.
Furthermore, we demonstrate that the UBLE can effectively activate the cGAS-STING pathway in tumor cells, enhancing NK cell-targeted cancer immunotherapy. This work develops a DNA lesion-gated strategy for on-demand activation and termination of the cGAS-STING pathway, affording an innovative avenue for enhancing cancer immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。